Aveanna Healthcare Holdings, Inc. (AVAH): Price and Financial Metrics
AVAH Price/Volume Stats
| Current price | $1.19 | 52-week high | $2.05 |
| Prev. close | $1.16 | 52-week low | $0.67 |
| Day low | $1.14 | Volume | 164,800 |
| Day high | $1.21 | Avg. volume | 294,695 |
| 50-day MA | $1.54 | Dividend yield | N/A |
| 200-day MA | $1.29 | Market Cap | 226.61M |
AVAH Stock Price Chart Interactive Chart >
AVAH POWR Grades
- Sentiment is the dimension where AVAH ranks best; there it ranks ahead of 95.53% of US stocks.
- AVAH's strongest trending metric is Value; it's been moving up over the last 177 days.
- AVAH's current lowest rank is in the Momentum metric (where it is better than 14.1% of US stocks).
AVAH Stock Summary
- AVEANNA HEALTHCARE HOLDINGS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 0.1% of US listed stocks.
- AVAH's price/sales ratio is 0.13; that's higher than the P/S ratio of merely 3.44% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 39.98 for AVEANNA HEALTHCARE HOLDINGS INC; that's greater than it is for 98.85% of US stocks.
- If you're looking for stocks that are quantitatively similar to AVEANNA HEALTHCARE HOLDINGS INC, a group of peers worth examining would be BGI, KIRK, CL, CPS, and CAH.
- Visit AVAH's SEC page to see the company's official filings. To visit the company's web site, go to www.aveanna.com.
AVAH Valuation Summary
- AVAH's price/sales ratio is 0.1; this is 94.74% lower than that of the median Healthcare stock.
- Over the past 29 months, AVAH's price/sales ratio has gone down 1.3.
Below are key valuation metrics over time for AVAH.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| AVAH | 2023-09-22 | 0.1 | -35.0 | -1.1 | -19.7 |
| AVAH | 2023-09-21 | 0.1 | -35.3 | -1.1 | -19.8 |
| AVAH | 2023-09-20 | 0.1 | -36.5 | -1.1 | -19.9 |
| AVAH | 2023-09-19 | 0.1 | -38.2 | -1.2 | -20.0 |
| AVAH | 2023-09-18 | 0.1 | -38.7 | -1.2 | -20.0 |
| AVAH | 2023-09-15 | 0.1 | -39.6 | -1.2 | -20.1 |
Aveanna Healthcare Holdings, Inc. (AVAH) Company Bio
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which our caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; unskilled nursing services; and employer of record support services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers a line of durable medical equipment and enteral nutrition supplies to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Latest AVAH News From Around the Web
Below are the latest news stories about AVEANNA HEALTHCARE HOLDINGS INC that investors may wish to consider to help them evaluate AVAH as an investment opportunity.
Analysts Expect Breakeven For Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Before LongWith the business potentially at an important milestone, we thought we'd take a closer look at Aveanna Healthcare... |
Q2 2023 Aveanna Healthcare Holdings Inc Earnings CallQ2 2023 Aveanna Healthcare Holdings Inc Earnings Call |
Aveanna (AVAH) Reports Q2 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
Aveanna Healthcare (AVAH) Reports Q2 Loss, Tops Revenue EstimatesAveanna (AVAH) delivered earnings and revenue surprises of 50% and 4.14%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? |
Aveanna Healthcare Holdings Announces Second Quarter 2023 Financial ResultsRevenue was $471.9 million, a 6.5% increase over the prior year Gross margin increased 7.0% to $155.3 million, compared to Q2 2022 Net income was $25.6 million, compared to net loss of $473.9 million in the comparable prior year period Adjusted EBITDA was $35.8 million, a sequential increase of 25.6% and a 3.2% decrease as compared to the prior year Full year 2023 revenue guidance raised to a range of $1,850 million to $1,860 million Full year 2023 Adjusted EBITDA guidance raised to a range of $ |
AVAH Price Returns
| 1-mo | -17.36% |
| 3-mo | -29.59% |
| 6-mo | 14.42% |
| 1-year | -27.66% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 52.56% |
| 2022 | -89.46% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...